Using the EMT6 murine tumour model that recapitulates this immune-excluded tumour phenotype, combined blockade of PD-L1 and TGFβ reprogrammed peritumoral fibroblasts converted tumours from an excluded to inflamed phenotype resulting in a reduction in tumour burden.18 This evidence concerns the gene TGFB1 and neoplasm.